Deutsch English Français

Contact

EP1674080

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1674080

EP1674080 - Solid pharmaceutical composition comprising valsartan [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 17.08.2007 Database last updated on 31.08.2024
Most recent event Tooltip	17.08.2007	Application deemed to be withdrawn	published on 19.09.2007 [2007/38]
Applicant(s)	For all designated states KRKA, D.D., Novo Mesto Smarjeska cesta 6 8501 Novo mesto / SI
	[2006/26]
Inventor(s)	01 / Vrbinc, Miha Gotna vas 20 8000 Novo mesto / SI
	02 / Slanc, Janika Velili Vrh 40a 1270 Litija / SI
	03 / Rangus, Marija Gorenje Gradisce 1 8310 Sentjernej / SI
	04 / Zupancic, Silvo Seidlova cesta 34 8000 Novo mesto / SI
	05 / Bevec, Franci Grm 20 8210 Trebnje / SI
	[2006/26]
Representative(s)	Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastrasse 30 81925 München / DE
	[N/P]
Former [2006/26]	HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE
Application number, filing date	04030782.9	24.12.2004
	[2006/26]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP1674080
	Date:	28.06.2006
	Language:	EN
	[2006/26]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	04.08.2005
Classification	IPC:	A61K9/14	[2006/26]
	CPC:	A61K9/2081 (EP); A61K9/2866 (EP); A61P9/12 (EP)
Designated contracting states	(deleted) [2007/10]
Former [2006/26]	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR
Title	German:	Feste pharmazeutische Zusammensetzung valsartan enthaltend	[2006/26]
	English:	Solid pharmaceutical composition comprising valsartan	[2006/26]
	French:	Composition pharmaceutique comprenant du valsartan	[2006/26]
Examination procedure	29.12.2006	Application deemed to be withdrawn, date of legal effect [2007/38]
	24.04.2007	Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2007/38]
Fees paid	Penalty fee
	Penalty fee Rule 85a EPC 1973
	05.02.2007	AT M01 Not yet paid
	05.02.2007	BE M01 Not yet paid
	05.02.2007	BG M01 Not yet paid
	05.02.2007	CH M01 Not yet paid
	05.02.2007	CY M01 Not yet paid
	05.02.2007	CZ M01 Not yet paid
	05.02.2007	DE M01 Not yet paid
	05.02.2007	DK M01 Not yet paid
	05.02.2007	EE M01 Not yet paid
	05.02.2007	ES M01 Not yet paid
	05.02.2007	FI M01 Not yet paid
	05.02.2007	FR M01 Not yet paid
	05.02.2007	GB M01 Not yet paid
	05.02.2007	GR M01 Not yet paid
	05.02.2007	HU M01 Not yet paid
	05.02.2007	IE M01 Not yet paid
	05.02.2007	IS M01 Not yet paid
	05.02.2007	IT M01 Not yet paid
	05.02.2007	LT M01 Not yet paid
	05.02.2007	LU M01 Not yet paid
	05.02.2007	MC M01 Not yet paid
	05.02.2007	NL M01 Not yet paid
	05.02.2007	PL M01 Not yet paid
	05.02.2007	PT M01 Not yet paid
	05.02.2007	RO M01 Not yet paid
	05.02.2007	SE M01 Not yet paid
	05.02.2007	SI M01 Not yet paid
	05.02.2007	SK M01 Not yet paid
	05.02.2007	TR M01 Not yet paid
	Penalty fee Rule 85b EPC 1973
	05.02.2007	M01 Not yet paid
	Additional fee for renewal fee
	31.12.2006	03 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]EP0914119 (NOVARTIS AG [CH]) [X] 1-21 * examples 1-3; claim 36 * * claim 36 *;
		[A]US6211217 (SPINALE FRANCIS G [US], et al) [A] 8,11,14-16 * column 17 - column 18 * * examples 5,6 *;
		[A]WO0176574 (NOVARTIS AG [CH], et al) [A] 8,11,13-16 * page 19 *;
		[A]US2003035832 (KATAKUSE YOSHIMITSU [JP], et al) [A] 8-16 * page 5, column R, paragraphs 84-86 *;
		[A]US2003207930 (MARTI ERWIN [CH], et al) [A] 8,11,14-16 * page 21, paragraph 308 - paragraph 309 *;
		[X]EP1410797 (NOVARTIS AG [CH], et al) [X] 1-21 * paragraph [0017] - paragraph [0025] * * examples 1-3 *;
		[A]WO2004094392 (TEVA PHARMA [IL], et al) [A] 18-21 * page 15, line 25 - line 30 *;
		[Y]WO2004094391 (TEVA PHARMA [IL], et al) [Y] 1-21 * page 20, line 22 - line 25 *;
		[Y]WO2004105694 (LIPOCINE INC [US], et al) [Y] 1-21* paragraphs [0021] , [0045] *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p